Scarabin PY - Search Results

1

Elevated plasma fibrinogen and increased fibrin turnover among healthy women who both smoke and use low-dose oral contraceptives--a preliminary report.

Scarabin PY, Vissac AM, Kirzin JM, Bourgeat P, Amiral J, Agher R, Guize L. Scarabin PY, et al. Thromb Haemost. 1999 Sep;82(3):1112-6. Thromb Haemost. 1999. PMID: 10494773

2

Haemostatic variables and menopausal status: influence of hormone replacement therapy.

Scarabin PY, Plu-Bureau G, Bara L, Bonithon-Kopp C, Guize L, Samama MM. Scarabin PY, et al. Thromb Haemost. 1993 Oct 18;70(4):584-7. Thromb Haemost. 1993. PMID: 8115983 Clinical Trial.

3

Factor VII activation and oral contraceptives.

Plu-Bureau G, Scarabin PY, Bara L, Malmejac A, Guize L, Samama M. Plu-Bureau G, et al. Among authors: scarabin py. Thromb Res. 1993 May 1;70(3):275-80. doi: 10.1016/0049-3848(93)90135-b. Thromb Res. 1993. PMID: 8327993

4

Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.

Scarabin PY, Plu-Bureau G, Zitoun D, Bara L, Guize L, Samama MM. Scarabin PY, et al. Thromb Haemost. 1995 Sep;74(3):928-32. Thromb Haemost. 1995. PMID: 8571323

5

Population correlates of coagulation factor VII. Importance of age, sex, and menopausal status as determinants of activated factor VII.

Scarabin PY, Vissac AM, Kirzin JM, Bourgeat P, Amiral J, Agher R, Guize L. Scarabin PY, et al. Arterioscler Thromb Vasc Biol. 1996 Sep;16(9):1170-6. doi: 10.1161/01.atv.16.9.1170. Arterioscler Thromb Vasc Biol. 1996. PMID: 8792771 Clinical Trial.

6

Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial.

Scarabin PY, Alhenc-Gelas M, Plu-Bureau G, Taisne P, Agher R, Aiach M. Scarabin PY, et al. Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):3071-8. doi: 10.1161/01.atv.17.11.3071. Arterioscler Thromb Vasc Biol. 1997. PMID: 9409295 Clinical Trial.

7

Impact of progestagens on activated protein C (APC) resistance among users of oral contraceptives.

Alhenc-Gelas M, Plu-Bureau G, Guillonneau S, Kirzin JM, Aiach M, Ochat N, Scarabin PY. Alhenc-Gelas M, et al. Among authors: scarabin py. J Thromb Haemost. 2004 Sep;2(9):1594-600. doi: 10.1111/j.1538-7836.2004.00894.x. J Thromb Haemost. 2004. PMID: 15333036 Free article.

8

Association of circulating cellular adhesion molecules with menopausal status and hormone replacement therapy. Time-dependent change in transdermal, but not oral estrogen users.

Oger E, Alhenc-Gelas M, Plu-Bureau G, Mennen L, Cambillau M, Guize L, Pujol Y, Scarabin P. Oger E, et al. Thromb Res. 2001 Jan 15;101(2):35-43. doi: 10.1016/s0049-3848(00)00382-0. Thromb Res. 2001. PMID: 11342204

9

Risk factors for early carotid atherosclerosis in middle-aged French women.

Bonithon-Kopp C, Scarabin PY, Taquet A, Touboul PJ, Malmejac A, Guize L. Bonithon-Kopp C, et al. Among authors: scarabin py. Arterioscler Thromb. 1991 Jul-Aug;11(4):966-72. doi: 10.1161/01.atv.11.4.966. Arterioscler Thromb. 1991. PMID: 2065047

10

Factor VII activation and menopausal status.

Scarabin PY, Bonithon-Kopp C, Bara L, Malmejac A, Guize L, Samama M. Scarabin PY, et al. Thromb Res. 1990 Jan 15;57(2):227-34. doi: 10.1016/0049-3848(90)90322-4. Thromb Res. 1990. PMID: 2315887

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

140 results

Search Page

Filters